Span Divergent Ltd
₹ 34.9
0.00%
09 Mar
- close price
About
Incorporated in 1972, Span Divergent Ltd deals in different businesses through various subsidiaries.[1]
Key Points
- Market Cap ₹ 19.1 Cr.
- Current Price ₹ 34.9
- High / Low ₹ 35.2 / 19.0
- Stock P/E 38.9
- Book Value ₹ 64.6
- Dividend Yield 0.00 %
- ROCE 1.37 %
- ROE 1.25 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.54 times its book value
- Market value of investments Rs.29.3 Cr. is more than the Market Cap Rs.19.1 Cr.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- The company has delivered a poor sales growth of -1.20% over past five years.
- Company has a low return on equity of 1.47% over last 3 years.
- Debtor days have increased from 47.0 to 74.8 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Loading peers table ...
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 78.37 | 72.71 | 0.00 | 2.39 | 1.70 | 1.73 | 1.71 | 1.46 | 1.96 | 1.96 | 1.91 | 1.61 | 1.43 | |
| 74.43 | 71.21 | 5.08 | 6.58 | 5.99 | 2.97 | 2.02 | 1.39 | 1.50 | 1.46 | 1.68 | 1.59 | 1.68 | |
| Operating Profit | 3.94 | 1.50 | -5.08 | -4.19 | -4.29 | -1.24 | -0.31 | 0.07 | 0.46 | 0.50 | 0.23 | 0.02 | -0.25 |
| OPM % | 5.03% | 2.06% | -175.31% | -252.35% | -71.68% | -18.13% | 4.79% | 23.47% | 25.51% | 12.04% | 1.24% | -17.48% | |
| 1.01 | 49.37 | 9.99 | 4.02 | 2.77 | -0.60 | 0.96 | 0.64 | -8.03 | -3.37 | 1.63 | 1.21 | 1.33 | |
| Interest | 4.41 | 4.36 | 0.00 | 0.17 | 0.70 | 0.17 | 0.23 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 4.77 | 5.83 | 0.17 | 0.34 | 0.56 | 1.12 | 0.92 | 0.65 | 0.51 | 0.42 | 0.34 | 0.25 | 0.25 |
| Profit before tax | -4.23 | 40.68 | 4.74 | -0.68 | -2.78 | -3.13 | -0.50 | 0.02 | -8.08 | -3.29 | 1.52 | 0.98 | 0.83 |
| Tax % | 21.51% | 13.59% | 25.74% | 23.53% | 10.79% | 3.51% | -28.00% | 100.00% | -3.96% | 1.22% | 0.00% | 14.29% | |
| -5.14 | 35.15 | 3.53 | -0.84 | -3.08 | -3.24 | -0.35 | 0.00 | -7.76 | -3.34 | 1.51 | 0.84 | 0.81 | |
| EPS in Rs | -7.06 | 48.31 | 6.46 | -1.54 | -5.64 | -5.93 | -0.64 | 0.00 | -14.21 | -6.12 | 2.76 | 1.54 | 1.49 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -32% |
| 5 Years: | -1% |
| 3 Years: | -6% |
| TTM: | -20% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 21% |
| 3 Years: | -21% |
| TTM: | -66% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -6% |
| 5 Years: | 22% |
| 3 Years: | 42% |
| 1 Year: | 12% |
| Return on Equity | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | 1% |
| 3 Years: | 1% |
| Last Year: | 1% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7.28 | 7.28 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 | 5.46 |
| Reserves | 16.46 | 51.51 | 45.07 | 45.03 | 41.95 | 38.63 | 38.26 | 38.27 | 30.51 | 27.16 | 28.66 | 29.29 | 29.83 |
| 37.44 | 0.00 | 0.00 | 8.50 | 9.82 | 4.19 | 2.89 | 3.14 | 2.86 | 2.75 | 2.08 | 2.23 | 2.18 | |
| 29.00 | 3.54 | 0.46 | 1.01 | 1.62 | 1.32 | 2.80 | 2.97 | 1.96 | 2.18 | 2.16 | 2.90 | 3.11 | |
| Total Liabilities | 90.18 | 62.33 | 50.99 | 60.00 | 58.85 | 49.60 | 49.41 | 49.84 | 40.79 | 37.55 | 38.36 | 39.88 | 40.58 |
| 42.56 | 0.40 | 2.12 | 5.89 | 9.28 | 8.17 | 5.52 | 4.87 | 4.28 | 3.86 | 3.31 | 3.38 | 3.27 | |
| CWIP | 4.41 | 0.00 | 0.03 | 0.92 | 0.00 | 0.01 | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.64 | 46.36 | 38.39 | 44.78 | 47.02 | 39.79 | 40.02 | 42.88 | 35.10 | 31.86 | 33.22 | 35.15 | 36.11 |
| 42.57 | 15.57 | 10.45 | 8.41 | 2.55 | 1.63 | 3.85 | 2.07 | 1.41 | 1.83 | 1.83 | 1.35 | 1.20 | |
| Total Assets | 90.18 | 62.33 | 50.99 | 60.00 | 58.85 | 49.60 | 49.41 | 49.84 | 40.79 | 37.55 | 38.36 | 39.88 | 40.58 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.99 | 44.99 | -4.14 | -0.93 | 2.44 | -1.09 | 1.10 | 0.37 | -0.31 | 0.58 | 0.53 | 1.00 | |
| -5.60 | -5.83 | 10.26 | -8.56 | -2.52 | 6.39 | 0.47 | -0.57 | 0.43 | -0.36 | 0.16 | -1.10 | |
| -3.92 | -32.35 | -12.16 | 8.33 | 0.67 | -5.82 | -1.97 | 0.30 | -0.20 | -0.02 | -0.56 | 0.15 | |
| Net Cash Flow | -0.53 | 6.81 | -6.04 | -1.16 | 0.59 | -0.52 | -0.41 | 0.10 | -0.08 | 0.20 | 0.13 | 0.04 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 81.60 | 0.00 | 0.00 | 62.26 | 50.64 | 49.09 | 30.00 | 18.62 | 29.80 | 36.31 | 74.81 | |
| Inventory Days | 190.61 | 0.00 | 0.00 | |||||||||
| Days Payable | 117.23 | |||||||||||
| Cash Conversion Cycle | 154.98 | 0.00 | 0.00 | 62.26 | 50.64 | 49.09 | 30.00 | 18.62 | 29.80 | 36.31 | 74.81 | |
| Working Capital Days | -71.63 | -10.44 | -867.45 | -1,945.24 | -748.99 | 53.36 | -202.50 | -134.08 | -191.81 | -173.90 | -358.20 | |
| ROCE % | 0.28% | -3.68% | -5.58% | -5.97% | -6.11% | -2.54% | -1.33% | 0.02% | 1.31% | 1.73% | 1.26% | 1.37% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Number of Permanent Employees (Standalone) count |
|
||||||||||
| Median Remuneration of Employees INR |
|||||||||||
| Revenue by Segment - Cashew Processing INR Lacs |
|||||||||||
| Revenue by Segment - Tissue Culture INR Lacs |
|||||||||||
| Revenue by Segment - Trading (Life Sciences/Healthcare) INR Lacs |
|||||||||||
| Biological Asset Valuation (Tissue Culture) INR Lacs |
|||||||||||
Requires Premium
Requires Premium
Documents
Announcements
-
Announcement Under Regulation 30 (LODR)
25 Feb - Issued corporate guarantee up to Rs.5,00,00,000 to HDFC Bank for Dryfruit Factory LLP, dated Feb 25, 2026.
-
Board Meeting Outcome for Span Divergent Limited- Outcome Of Board Meeting Held On February 25, 2026
25 Feb - Board approved corporate guarantee up to Rs5,00,00,000 for Dryfruit Factory LLP’s HDFC Bank facilities (25 Feb 2026).
-
Announcement under Regulation 30 (LODR)-Preferential Issue
21 Feb - Preferential issue of 1,801,481 shares at Rs.32.16 to Mr. Neev Nirav Jogani, approved Feb 20, 2026.
-
Announcement under Regulation 30 (LODR)-Issue of Securities
21 Feb - Approved preferential issue of 1,801,481 shares at Rs32.16 each to Mr. Neev Jogani (24.80%), raising ~Rs5.79 crore.
-
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
21 Feb - EGM approved preferential issue of 1,801,481 shares at Rs32.16 to Mr. Neev Jogani (post-holding 24.80%).
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1][2]
SDL operates across multiple business segments through dedicated subsidiaries in the Food, Agriculture, and Life Sciences verticals. It also provides management consulting and support services, offering financial, technical, and operational expertise to its group entities. The company actively oversees compliance, networking, and business development activities, while closely monitoring subsidiary performance and implementing strategic guidance and corrective measures as approved by the Board.